1	Two	two	_	_	_	_	_	_	_
2	distinct	distinct	_	_	_	_	_	_	_
3	signal	signal	_	_	_	_	_	_	_
4	transmission	transmission	_	_	_	_	_	_	_
5	pathways	pathway	_	_	_	_	_	_	_
6	in	in	_	_	_	_	_	_	_
7	T	t	_	_	_	_	_	_	_
8	lymphocytes	lymphocyte	_	_	_	_	_	_	_
9	are	be	_	_	_	_	_	_	_
10	inhibited	inhibit	_	_	_	_	_	_	_
11	by	by	_	_	_	_	_	_	_
12	complexes	complex	_	_	_	_	_	_	_
13	formed	form	_	_	_	_	_	_	_
14	between	between	_	_	_	_	_	_	_
15	an	an	_	_	_	_	_	_	_
16	immunophilin	immunophilin	_	_	_	_	_	_	_
17	and	and	_	_	_	_	_	_	_
18	either	either	_	_	_	_	_	_	_
19	FK506	FK506	_	_	_	_	_	_	_
20	or	or	_	_	_	_	_	_	_
21	rapamycin	rapamycin	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Proliferation	proliferation	_	_	_	_	_	_	_
2	and	and	_	_	_	_	_	_	_
3	immunologic	immunologic	_	_	_	_	_	_	_
4	function	function	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	T	t	_	_	_	_	_	_	_
7	lymphocytes	lymphocyte	_	_	_	_	_	_	_
8	are	be	_	_	_	_	_	_	_
9	initiated	initiate	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	signals	signal	_	_	_	_	_	_	_
12	from	from	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	antigen	antigen	_	_	_	_	_	_	_
15	receptor	receptor	_	_	_	_	_	_	_
16	that	that	_	_	_	_	_	_	_
17	are	be	_	_	_	_	_	_	_
18	inhibited	inhibit	_	_	_	_	_	_	_
19	by	by	_	_	_	_	_	_	_
20	the	the	_	_	_	_	_	_	_
21	immunosuppressant	immunosuppressant	_	_	_	_	_	_	_
22	FK506	FK506	_	_	_	_	_	_	_
23	but	but	_	_	_	_	_	_	_
24	not	not	_	_	_	_	_	_	_
25	by	by	_	_	_	_	_	_	_
26	its	its	_	_	_	_	_	_	_
27	structural	structural	_	_	_	_	_	_	_
28	analog	analog	_	_	_	_	_	_	_
29	,	,	_	_	_	_	_	_	_
30	rapamycin	rapamycin	_	_	_	_	_	_	_
31	.	.	_	_	_	_	_	_	_

1	On	on	_	_	_	_	_	_	_
2	the	the	_	_	_	_	_	_	_
3	other	other	_	_	_	_	_	_	_
4	hand	hand	_	_	_	_	_	_	_
5	,	,	_	_	_	_	_	_	_
6	interleukin	interleukin	_	_	_	_	_	_	_
7	2	2	_	_	_	_	_	_	_
8	(	(	_	_	_	_	_	_	_
9	IL-2)-induced	il-2)-induced	_	_	_	_	_	_	_
10	signals	signal	_	_	_	_	_	_	_
11	are	be	_	_	_	_	_	_	_
12	blocked	block	_	_	_	_	_	_	_
13	by	by	_	_	_	_	_	_	_
14	rapamycin	rapamycin	_	_	_	_	_	_	_
15	but	but	_	_	_	_	_	_	_
16	not	not	_	_	_	_	_	_	_
17	by	by	_	_	_	_	_	_	_
18	FK506	FK506	_	_	_	_	_	_	_
19	.	.	_	_	_	_	_	_	_

1	Remarkably	remarkably	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	two	two	_	_	_	_	_	_	_
5	drugs	drug	_	_	_	_	_	_	_
6	inhibit	inhibit	_	_	_	_	_	_	_
7	each	each	_	_	_	_	_	_	_
8	other	other	_	_	_	_	_	_	_
9	â€™s	's	_	_	_	_	_	_	_
10	actions	action	_	_	_	_	_	_	_
11	,	,	_	_	_	_	_	_	_
12	raising	raise	_	_	_	_	_	_	_
13	the	the	_	_	_	_	_	_	_
14	possibility	possibility	_	_	_	_	_	_	_
15	that	that	_	_	_	_	_	_	_
16	both	both	_	_	_	_	_	_	_
17	act	act	_	_	_	_	_	_	_
18	by	by	_	_	_	_	_	_	_
19	means	mean	_	_	_	_	_	_	_
20	of	of	_	_	_	_	_	_	_
21	a	a	_	_	_	_	_	_	_
22	common	common	_	_	_	_	_	_	_
23	immunophilin	immunophilin	_	_	_	_	_	_	_
24	(	(	_	_	_	_	_	_	_
25	immunosuppressant	immunosuppressant	_	_	_	_	_	_	_
26	binding	binding	_	_	_	_	_	_	_
27	protein	protein	_	_	_	_	_	_	_
28	)	)	_	_	_	_	_	_	_
29	.	.	_	_	_	_	_	_	_

1	We	we	_	_	_	_	_	_	_
2	find	find	_	_	_	_	_	_	_
3	that	that	_	_	_	_	_	_	_
4	the	the	_	_	_	_	_	_	_
5	dissociation	dissociation	_	_	_	_	_	_	_
6	constant	constant	_	_	_	_	_	_	_
7	of	of	_	_	_	_	_	_	_
8	rapamycin	rapamycin	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	FK506	FK506	_	_	_	_	_	_	_
12	binding	binding	_	_	_	_	_	_	_
13	protein	protein	_	_	_	_	_	_	_
14	FKBP	FKBP	_	_	_	_	_	_	_
15	(	(	_	_	_	_	_	_	_
16	Kd	Kd	_	_	_	_	_	_	_
17	=	=	_	_	_	_	_	_	_
18	0.2	0.2	_	_	_	_	_	_	_
19	nM	nM	_	_	_	_	_	_	_
20	)	)	_	_	_	_	_	_	_
21	is	be	_	_	_	_	_	_	_
22	close	close	_	_	_	_	_	_	_
23	to	to	_	_	_	_	_	_	_
24	the	the	_	_	_	_	_	_	_
25	dissociation	dissociation	_	_	_	_	_	_	_
26	constant	constant	_	_	_	_	_	_	_
27	of	of	_	_	_	_	_	_	_
28	FK506	FK506	_	_	_	_	_	_	_
29	to	to	_	_	_	_	_	_	_
30	FKBP	FKBP	_	_	_	_	_	_	_
31	(	(	_	_	_	_	_	_	_
32	Kd	Kd	_	_	_	_	_	_	_
33	=	=	_	_	_	_	_	_	_
34	0.4	0.4	_	_	_	_	_	_	_
35	nM	nM	_	_	_	_	_	_	_
36	)	)	_	_	_	_	_	_	_
37	and	and	_	_	_	_	_	_	_
38	to	to	_	_	_	_	_	_	_
39	their	their	_	_	_	_	_	_	_
40	effective	effective	_	_	_	_	_	_	_
41	biologic	biologic	_	_	_	_	_	_	_
42	inhibitory	inhibitory	_	_	_	_	_	_	_
43	concentrations	concentration	_	_	_	_	_	_	_
44	.	.	_	_	_	_	_	_	_

1	However	however	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	an	an	_	_	_	_	_	_	_
4	excess	excess	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	rapamycin	rapamycin	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	needed	need	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	revert	revert	_	_	_	_	_	_	_
11	FK506-mediated	fk506-mediated	_	_	_	_	_	_	_
12	inhibition	inhibition	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	IL-2	il-2	_	_	_	_	_	_	_
15	production	production	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	apoptosis	apoptosis	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	transcriptional	transcriptional	_	_	_	_	_	_	_
21	activation	activation	_	_	_	_	_	_	_
22	of	of	_	_	_	_	_	_	_
23	NF-AT	NF-AT	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	a	a	_	_	_	_	_	_	_
26	T-cell-specific	t-cell-specific	_	_	_	_	_	_	_
27	transcription	transcription	_	_	_	_	_	_	_
28	factor	factor	_	_	_	_	_	_	_
29	necessary	necessary	_	_	_	_	_	_	_
30	for	for	_	_	_	_	_	_	_
31	IL-2	il-2	_	_	_	_	_	_	_
32	gene	gene	_	_	_	_	_	_	_
33	activation	activation	_	_	_	_	_	_	_
34	.	.	_	_	_	_	_	_	_

1	Similarly	similarly	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	an	an	_	_	_	_	_	_	_
4	excess	excess	_	_	_	_	_	_	_
5	of	of	_	_	_	_	_	_	_
6	FK506	FK506	_	_	_	_	_	_	_
7	is	be	_	_	_	_	_	_	_
8	needed	need	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	revert	revert	_	_	_	_	_	_	_
11	rapamycin-mediated	rapamycin-mediated	_	_	_	_	_	_	_
12	inhibition	inhibition	_	_	_	_	_	_	_
13	of	of	_	_	_	_	_	_	_
14	IL-2-induced	il-2-induced	_	_	_	_	_	_	_
15	proliferation	proliferation	_	_	_	_	_	_	_
16	.	.	_	_	_	_	_	_	_

1	The	the	_	_	_	_	_	_	_
2	drug	drug	_	_	_	_	_	_	_
3	concentrations	concentration	_	_	_	_	_	_	_
4	required	require	_	_	_	_	_	_	_
5	for	for	_	_	_	_	_	_	_
6	antagonism	antagonism	_	_	_	_	_	_	_
7	may	may	_	_	_	_	_	_	_
8	be	be	_	_	_	_	_	_	_
9	explained	explain	_	_	_	_	_	_	_
10	by	by	_	_	_	_	_	_	_
11	the	the	_	_	_	_	_	_	_
12	relative	relative	_	_	_	_	_	_	_
13	affinity	affinity	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	drugs	drug	_	_	_	_	_	_	_
17	to	to	_	_	_	_	_	_	_
18	,	,	_	_	_	_	_	_	_
19	and	and	_	_	_	_	_	_	_
20	by	by	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	abundance	abundance	_	_	_	_	_	_	_
23	of	of	_	_	_	_	_	_	_
24	,	,	_	_	_	_	_	_	_
25	the	the	_	_	_	_	_	_	_
26	immunophilin	immunophilin	_	_	_	_	_	_	_
27	FKBP	FKBP	_	_	_	_	_	_	_
28	.	.	_	_	_	_	_	_	_

1	FKBP	FKBP	_	_	_	_	_	_	_
2	has	have	_	_	_	_	_	_	_
3	been	be	_	_	_	_	_	_	_
4	shown	show	_	_	_	_	_	_	_
5	to	to	_	_	_	_	_	_	_
6	catalyze	catalyze	_	_	_	_	_	_	_
7	the	the	_	_	_	_	_	_	_
8	interconversion	interconversion	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	the	the	_	_	_	_	_	_	_
11	cis-	cis-	_	_	_	_	_	_	_
12	and	and	_	_	_	_	_	_	_
13	trans-rotamers	trans-rotamer	_	_	_	_	_	_	_
14	of	of	_	_	_	_	_	_	_
15	the	the	_	_	_	_	_	_	_
16	peptidyl-prolyl	peptidyl-prolyl	_	_	_	_	_	_	_
17	amide	amide	_	_	_	_	_	_	_
18	bond	bond	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	peptide	peptide	_	_	_	_	_	_	_
21	substrates	substrate	_	_	_	_	_	_	_
22	;	;	_	_	_	_	_	_	_
23	here	here	_	_	_	_	_	_	_
24	we	we	_	_	_	_	_	_	_
25	show	show	_	_	_	_	_	_	_
26	that	that	_	_	_	_	_	_	_
27	rapamycin	rapamycin	_	_	_	_	_	_	_
28	,	,	_	_	_	_	_	_	_
29	like	like	_	_	_	_	_	_	_
30	FK506	FK506	_	_	_	_	_	_	_
31	,	,	_	_	_	_	_	_	_
32	is	be	_	_	_	_	_	_	_
33	a	a	_	_	_	_	_	_	_
34	potent	potent	_	_	_	_	_	_	_
35	inhibitor	inhibitor	_	_	_	_	_	_	_
36	of	of	_	_	_	_	_	_	_
37	the	the	_	_	_	_	_	_	_
38	rotamase	rotamase	_	_	_	_	_	_	_
39	activity	activity	_	_	_	_	_	_	_
40	of	of	_	_	_	_	_	_	_
41	FKBP	FKBP	_	_	_	_	_	_	_
42	(	(	_	_	_	_	_	_	_
43	Ki	Ki	_	_	_	_	_	_	_
44	=	=	_	_	_	_	_	_	_
45	0.2	0.2	_	_	_	_	_	_	_
46	nM	nM	_	_	_	_	_	_	_
47	)	)	_	_	_	_	_	_	_
48	.	.	_	_	_	_	_	_	_

1	Neither	neither	_	_	_	_	_	_	_
2	FKBP	FKBP	_	_	_	_	_	_	_
3	binding	binding	_	_	_	_	_	_	_
4	nor	nor	_	_	_	_	_	_	_
5	inhibition	inhibition	_	_	_	_	_	_	_
6	of	of	_	_	_	_	_	_	_
7	rotamase	rotamase	_	_	_	_	_	_	_
8	activity	activity	_	_	_	_	_	_	_
9	of	of	_	_	_	_	_	_	_
10	FKBP	FKBP	_	_	_	_	_	_	_
11	alone	alone	_	_	_	_	_	_	_
12	is	be	_	_	_	_	_	_	_
13	sufficient	sufficient	_	_	_	_	_	_	_
14	to	to	_	_	_	_	_	_	_
15	explain	explain	_	_	_	_	_	_	_
16	the	the	_	_	_	_	_	_	_
17	biologic	biologic	_	_	_	_	_	_	_
18	actions	action	_	_	_	_	_	_	_
19	of	of	_	_	_	_	_	_	_
20	these	these	_	_	_	_	_	_	_
21	drugs	drug	_	_	_	_	_	_	_
22	.	.	_	_	_	_	_	_	_

1	Rather	rather	_	_	_	_	_	_	_
2	,	,	_	_	_	_	_	_	_
3	these	these	_	_	_	_	_	_	_
4	findings	finding	_	_	_	_	_	_	_
5	suggest	suggest	_	_	_	_	_	_	_
6	that	that	_	_	_	_	_	_	_
7	immunophilin	immunophilin	_	_	_	_	_	_	_
8	bound	bind	_	_	_	_	_	_	_
9	to	to	_	_	_	_	_	_	_
10	FK506	FK506	_	_	_	_	_	_	_
11	interferes	interfere	_	_	_	_	_	_	_
12	with	with	_	_	_	_	_	_	_
13	antigen	antigen	_	_	_	_	_	_	_
14	receptor-induced	receptor-induced	_	_	_	_	_	_	_
15	signals	signal	_	_	_	_	_	_	_
16	,	,	_	_	_	_	_	_	_
17	while	while	_	_	_	_	_	_	_
18	rapamycin	rapamycin	_	_	_	_	_	_	_
19	bound	bind	_	_	_	_	_	_	_
20	to	to	_	_	_	_	_	_	_
21	the	the	_	_	_	_	_	_	_
22	immunophilin	immunophilin	_	_	_	_	_	_	_
23	interferes	interfere	_	_	_	_	_	_	_
24	with	with	_	_	_	_	_	_	_
25	IL-2-induced	il-2-induced	_	_	_	_	_	_	_
26	signals	signal	_	_	_	_	_	_	_
27	.	.	_	_	_	_	_	_	_

